Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
Dominik A BarthFlorian MoikSarah SteinlechnerFlorian PoschMarie-Christina MayerAmelie M SandnerFranziska BertonVerena SchlintlLukas KochNikolaus JohnRobert WurmMartin PichlerThomas BauernhoferPatrick ReimannChristoph WohlkönigErika RichtigThomas WinderMatthias PreusserPhilipp J JostCihan AyArmin GergerAngelika TerbuchJakob Michael RiedlPublished in: Journal for immunotherapy of cancer (2023)
Early CRP kinetics represent a tumor-agnostic predictor for treatment response, progression risk and mortality in patients with cancer undergoing ICI therapy.